<!DOCTYPE html><html><head><title>BBIO BridgeBio Pharma, Inc. Stock Quote</title><meta charset="UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=edge">                         <meta name="viewport" content="width=1024"><meta name="description" content="Stock screener for investors and traders, financial visualizations."><meta name="keywords" content="Stock Screener, Charts, Quotes, Maps, News, Financial Visualizations, Research, Trading Systems"><meta http-equiv="imagetoolbar" content="no"><meta http-equiv="pragma" content="no-cache"><meta http-equiv="cache-control" content="no-cache"><meta http-equiv="Expires" content="-1">            <link rel="preload" href="/fonts/lato-v17-latin-ext_latin-regular.woff2" as="font" crossorigin>            <link rel="preload" href="/fonts/lato-v17-latin-ext_latin-700.woff2" as="font" crossorigin>            <link rel="preload" href="/fonts/lato-v17-latin-ext_latin-900.woff2" as="font" crossorigin>            <link rel="preload" href="/fonts/inter-latin.woff2" as="font" crossorigin>        <link rel="stylesheet" href="/assets/dist/finviz.4a466aa9.css" type="text/css"><link rel="stylesheet" href="/assets/dist/main.333dc3ef.css" type="text/css"><link rel="icon" type="image/png" href="/favicon_2x.png" sizes="32x32"><link rel="icon" type="image/png" href="/favicon.png" sizes="16x16"><script type="text/javascript">FinvizSettings = {hasUserPremium: false, name: "", chartsDomain: "https://charts2.finviz.com", nodeChartsDomain: "", hasUserPersistentDrawings: false, hasUserNodeCharts: false, hasUserStickyHeader: false};</script><script src="/script/boxover.js?rev=288" type="text/javascript"></script><script type="text/javascript" src="/js/libs/d3-json.js"></script><script src="/script/libs/browser_support.js?rev=288" type="text/javascript"></script>            <script type="text/javascript" src="/assets/dist/runtime.d6be941f.js"></script>            <script type="text/javascript" src="/assets/dist/vendors.ac1d54fd.js"></script>            <script type="text/javascript" src="/assets/dist/libs_init.7ba11a5a.js"></script>            <script type="text/javascript" src="/assets/dist/header.e0e26d9d.js"></script>        <script src="/script/ajax.js" type="text/javascript"></script><script src="/script/ta_settings.js?rev=288" type="text/javascript"></script><script>FinvizSettings.hasNewQuoteMenu = false;</script>            <script src="/js/dfp.min.js"></script>            <script>                if(window['FinvizLoadIC']) {                    var s = document.createElement('script');                    s.type = 'text/javascript';                    s.async = true;                    s.src = 'https://u5.investingchannel.com/static/uat.js';                    document.head.appendChild(s);                    InvestingChannelQueue = window.InvestingChannelQueue || [];                    var ic_page;                    InvestingChannelQueue.push(function() {                        ic_page = InvestingChannel.UAT.Run('df0d0d52-cc7f-11e8-82a5-0abbb61c4a6a');                    });                } else {                    (function() {                        function ready(fn) {if (document.readyState != 'loading'){fn();}else{document.addEventListener('DOMContentLoaded', fn);} }                        ready(function() {                            var banners = ['2', '4', '5', '6', '7'];                            var banner = banners[Math.floor(Math.random() * banners.length)];                            if (banner === '3') {                                document.getElementById('banner_position').innerHTML = '<iframe src="/img/a/' + banner + '/index.html?rev=2" frameBorder="0" width="728" height="90"></iframe>';                            } else {                                document.getElementById('banner_position').innerHTML = '<a href="/elite.ashx?utm_source=finviz&utm_medium=banner&utm_campaign=' + banner + '"><img src="/img/a/' + banner + '.jpg"></a>';                            }                            gtag && gtag('event', 'impression', { event_category: 'banner', event_label: banner, non_interaction: true });                        })                    })();                }            </script></head><body class="yellow-tooltip" style="margin:0" bgcolor="#ffffff"><div id="unsupported-browser">Your browser is no longer supported. Please, <a href="https://browser-update.org/update.html" target="_blank">upgrade your browser.</a></div>                <table class="header" width="100%" cellpadding="0" cellspacing="0" border="0" style="min-width: 1000px">                    <tr valign="top">                        <td>                            <script type="text/javascript">if(document.body.clientWidth>1500){document.write('<table align="center" width="1425px" cellpadding="0" cellspacing="0" border="0" style="table-layout: fixed; min-width: 1000px">')}else{document.write('<table align="center" width="95%" style="max-width: 1425px; min-width: 1000px; table-layout: fixed" cellpadding="0" cellspacing="0" border="0">')}</script>                                <tr>                                    <td width="30%">                                        <table width="100%" cellpadding="0" cellspacing="0" border="0">                                            <tr>                                                <td height="50" valign="middle">                                                    <a href="/" class="logo"></a>                                                </td>                                            </tr>                                            <tr>                                                <td class="search" id="search" style="padding-top: 4px">                                                    <form style="margin: 0">                                                        <input placeholder="Search ticker, company or profile" type="text" value="">                                                        <span class="fa fa-search"></span>                                                    </form>                                                </td>                                            </tr>                                        </table>                                    </td>                                    <td valign="bottom" style="padding-bottom: 4px">                                        <div id="microbar_position" style="height: 31px"></div>                                    </td>                                    <td width="728" align="right" style="position:relative;"><div id="banner_position" style="position:absolute;right:0;top:0;overflow:hidden;height:96px"></div></td>                                </tr>                            </table>                        </td>                    </tr>                    <tr>                        <td width="1000" style="font-size:0">                            <img src="/gfx/nic2x2.gif" width="1000" style="height:1px" border="0">                        </td>                    </tr>                </table>            <table class="navbar" width="100%" height="30" cellpadding="0" cellspacing="0" border="0">                <tr>                    <td height="30">                        <script type="text/javascript">if(document.body.clientWidth>1500){document.write('<table align="center" width="1425px" cellpadding="0" cellspacing="0" border="0" style="white-space: nowrap; min-width: 1000px">')}else{document.write('<table align="center" width="95%" style="max-width:1425px;white-space: nowrap;min-width: 1000px" cellpadding="0" cellspacing="0" border="0">')}</script>                            <tr height="30"><td><a class="nav-link  is-first" href="/">Home</a></td><td><a class="nav-link " href="/news.ashx">News</a></td><td><a class="nav-link " href="/screener.ashx">Screener</a></td><td><a class="nav-link " href="/map.ashx">Maps</a></td><td><a class="nav-link " href="/groups.ashx">Groups</a></td><td><a class="nav-link " href="/portfolio.ashx">Portfolio</a></td><td><a class="nav-link " href="/insidertrading.ashx">Insider</a></td><td><a class="nav-link " href="/futures.ashx">Futures</a></td><td><a class="nav-link " href="/forex.ashx">Forex</a></td><td><a class="nav-link " href="/crypto.ashx">Crypto</a></td><td><a class="nav-link " href="/backtests.ashx">Backtests</a></td><td><a class="nav-link  is-elite" href="/elite.ashx">Elite</a></td><td style="width: 100%"></td>                                <td class="time" id="time"></td>                <td>                    <a href="/help/screener.ashx" class="nav-link is-help">                        <span class="fa fa-question-circle"></span>                        Help                    </a>                </td>                <td><a href="/login.ashx" class="nav-link sign-in">Login</a></td>                <td><a href="/register.ashx" class="nav-link sign-up">Register</a></td>                                        </tr>                        </table>                    </td>                </tr>            </table>        <div class="content "><div class="fv-container">                    <div id="quote-ad" style="background: #fffce5; border: 1px solid #fee500; color: #363a46; display: none; font-family: Lato; font-size: 13px; line-height: 36px; text-align: center; width: 945px; margin: 10px auto 10px auto;position: relative;">                        <b>TIP: </b>                        <a href="/elite.ashx?utm_source=finviz&utm_medium=banner&utm_campaign=quote" target="blank" onclick="gtag('event', 'click', { event_category: 'bannerQuote' });" style="color: #1E6DC0;">Upgrade to FINVIZ*Elite</a> to get real-time quotes, intraday charts, and advanced charting tools.                        <a title="Close" class="close" onclick="Finviz.quoteAd.close();" href="javascript:void(0)" style="                            position: absolute;                            margin-right: 0;                            right: 10px;                            color: #363a46;                            text-decoration: none;	                    ">Ã—</a>                    </div>                    <script src="/js/quote_a.js?rev=2" async></script>        <table  style="margin: 21px auto 14px auto" cellpadding="0" cellspacing="0" border="0"><tr class="flex"><td class="fullview-links flex items-center" align="left" valign="center"><a href="javascript:void(0)" class="tab-link" id="publish-chart">publish chart</a>&nbsp;|&nbsp<a href="/save_to_portfolio.ashx?t=BBIO" class="tab-link">save to portfolio</a>&nbsp;|&nbsp<a href="/create_alert.ashx?t=BBIO" class="tab-link">create alert</a>&nbsp;<img src="/gfx/nic2x2.gif" style="width:20px;height:14px" border="0" alt=""><span class="count-text"><b>Type:</b></span> <a href="quote.ashx?t=BBIO&ty=c&ta=0&p=d" class="tab-link" data-testid="quote-compare-perf-link">candle</a>&nbsp;|&nbsp<a href="quote.ashx?t=BBIO&ty=l&ta=0&p=d" class="tab-link" data-testid="quote-compare-perf-link">line</a>&nbsp;|&nbsp<a href="quote.ashx?t=BBIO&ty=c&ta=1&p=d" class="tab-link" data-testid="quote-compare-perf-link"><b>advanced</b></a>&nbsp;|&nbsp<a href="/elite.ashx" class="tab-link">interactive</a>&nbsp;|&nbsp<a href="/elite.ashx" class="tab-link">perf</a>&nbsp;&nbsp;&nbsp;&nbsp;<span class="count-text"><b>Timeframe:</b></span> <a href="elite.ashx" class="tab-link">intraday</a>&nbsp;|&nbsp</span><a href="quote.ashx?t=BBIO&ty=c&ta=1&p=d" class="tab-link"><b>daily</b></a>&nbsp;|&nbsp<a href="quote.ashx?t=BBIO&ty=c&ta=0&p=w" class="tab-link">weekly</a>&nbsp;|&nbsp<a href="quote.ashx?t=BBIO&ty=c&ta=0&p=m" class="tab-link">monthly</a>&nbsp;&nbsp;</td><td class="flex items-center" align="left" valign="top" class="ta-settings-button" style="position: relative"><a href="elite.ashx" class="ta-settings-button">Settings<img src="gfx/ta_settings_arrow_d.gif" width="21" height="9" alt="" border="0"></a></td></tr></table><div id="js-settings-portal"></div></div></div><script>            FinvizSettings.TA = {"style":"candlestick","overlays":[{"name":"sma","parameters":"20","color":"rgba(220,  50, 179, 0.39)"},{"name":"sma","parameters":"50","color":"rgba(255, 143,  51, 0.78)"},{"name":"sma","parameters":"200","color":"rgba(220, 179,  50, 0.43)"},{"name":"patterns","parameters":"","color":"rgba(135, 206, 239, 1)|rgba(220, 159, 229, 1)"}],"indicators":[]};        </script><div style="display: flex; flex-direction: column; align-items: center">                <script>                    function checkSmallDisplay(configObject) {                        if ('d' === 'd' && window['FinvizSmallDisplay'] === true) {                            configObject.barWidth = 2;                            configObject.barMargin = 0;                            configObject.darkerWickColors = true;                            window['FinvizChartWidth'] = 990;                        }                        configObject.width = FinvizChartWidth;                    }                </script>                        <link rel="stylesheet" href="/assets/dist-charts/main.d4433d46.css">            <div id="app" class="interactive-chart">                <div id="chart" style="min-height: 400px; position: relative"></div>            </div>            <div id="js-charts-modal"><div class="overlay modal hidden has-footer"></div></div>            <div class="context-menu hidden"></div>                        <script>                (function(){                    var app = document.getElementById('app');                    var chart = document.getElementById('chart');                    window['FinvizChartWidthOriginal'] = 1280;                    window['FinvizChartWidth'] = 1280;                    var browserWidth = Math.max(document.documentElement.clientWidth, window.innerWidth || 0);                    if (browserWidth <= 1280){                        window['FinvizChartWidth'] = 992;                        window['FinvizSmallDisplay'] = true;                    }                } ())            </script>            <script type="text/javascript" src="/assets/dist-charts/vendors.7cd5f83d.js"></script>            <script type="text/javascript" src="/assets/dist-charts/main.b8b3420d.js"></script>        <div style="font-family:Verdana;font-size:11px;display:none;margin-bottom:15px" id="js-idea-note">Note:<br><textarea style="width:1280px;height:60px;display:block;border:1px solid #d3d3d3;padding: 2px 5px" id="note"></textarea></div><script>                                    (function() {                                        var Quote = FLibs.Charts.Quote;                                        var data = {"ticker":"BBIO","timeframe":"d","volume":[4986106,865466,325609,595465,2097780,399918,210618,94322,238872,230729,235872,156056,174112,109416,213303,298653,296856,192942,105074,116715,216703,101526,97883,77811,296691,148321,100611,60629,62760,85580,441211,216792,95540,128748,172927,218102,222721,159728,132992,100199,63845,112278,171908,144691,139796,136986,360780,200708,201353,227037,221915,221923,185196,176445,194077,173524,166006,167131,224993,3701133,401160,391772,306012,337014,412570,315563,192770,276565,406597,327804,217005,119451,170812,355492,262896,179258,180564,159728,148431,211357,169924,192230,259229,170563,326227,276966,295210,312394,342412,306515,172726,142833,107470,237792,290251,196745,229616,179336,185274,225761,460220,297694,446124,310895,362712,365404,262173,198333,67684,237368,617630,298250,228335,203694,419837,256938,161477,163278,201663,405465,391623,368368,362516,2790642,666682,510318,295848,870299,453603,387722,436688,845988,390523,330167,305107,343845,438332,472524,585383,355413,594462,236298,594839,332290,260859,500225,328055,267559,256800,298137,300337,342361,464477,345043,463502,403246,310032,452375,258887,226025,258660,248919,327794,355874,290034,536199,381935,302853,604447,709750,837086,479682,2125098,7529408,1043294,1760995,879228,1149474,998038,1419853,1231604,869804,1412860,1160625,9216532,1432709,905530,962399,966678,1016763,1176754,814472,744592,474099,670610,984040,1015653,1247344,1088870,1221191,1286350,1279549,951987,1342342,492089,370825,282963,355345,319140,442403,614025,431124,775150,473545,299516,842331,297878,589954,279502,447685,386730,465472,403803,419409,472053,357007,948367,389996,222811,561942,419146,523836,2447196,1337131,868574,563929,588444,1039187,532894,388160,372402,557829,455014,1057248,704328,1154706,1189310,3376426,1373308,1385139,445504,584180,1261060,482575,769796,1093507,624798,504353,501734,448610,470644,412498,615417,1038814,580823,326673,453235,311124,578973,634256,308776,318175,418573,328731,424578,290164,1003424,585932,290934,279007,248294,228094,297210,401457,634996,342341,375618,468445,191899,255053,402967,375735,307861,167126,184557,287498,169647,341215,607838,473952,306618,281258,725420,560999,643489,688878,1129076,593483,615879,661255,4690371,909240,651586,498568,389496,717880,374789,309866,414189,480103,376013,3228814,1517790,1633347,722341,1000766,489320,730835,698398,413731,861612,779754,660740,521653,611832,1312745,437214,422504,393327,362995,456916,305704,493505,629583,681945,506084,1130954,771045,537367,1221771,1033385,838285,504101,543435,298745,435509,512950,648852,535221,242497,1076123,848648,1639640,437025,265301,343477,530345,604290,468161,930723,1349032,692031,509224,361242,1495022,547820,448753,387317,302771,463525,664353,415678,436382,992753,727142,565870,787160,600827,578353,511803,1052367,847637,435476,510003,627089,446035,587804,2424661,4700773,3013022,1400505,1332748,1177151,1227969,973039,590954,1509282,1578476,726851,953921,446070,1722492,874508,847648,897236,1050327,644615,1151026,1081449,2175841,3058013,1165985,829642,1102987,1028863,865910,876717,1113963,1215089,777491,346292,461291,840953,709580,579924,2232658,994936,813745,629925,372378,851542,672357,772118,554773,782692,403173,645321,786060,347067,1544509,546949,998087,1362828,814516,510930,685293,397480,376308,426094,650712,370484,369226,411711,326281,684153,600199,593279,955113,1678922,729243,928547,761246,867372,923024,708553,729330,1180344,687169,592288,929807,622862,490631,492504,1029678,444069,910943,865929,557736,525781,1844798,896807,703215,1088285,556019,1105950,826520,1676360,2229610,2194115,1476508,1296629,1099880,668982,2769080,864689,879321,447868,531671,491985,451450,1024646,494349,627184,370867,357412,1223264,1938550,1205797,710676,933133,343913,816266,276703,883124,968137,753436,459375,1238080,783400,982252,458479,828645,474084,304098,756146,583829,416674,317787,570372,1400998,803395,725973,735656,795849,678806,495557,803817,990540,497062,871994,399453,536052,779218,633520,629668,787276,505373,919874,1633220,1100166,1031792,2566682,1252569,1299924,675406,2348956,861425,601630,857232,1620066,974962,789363,584193,583815,843206,839192,495740,760381,986316,981191,812345,511460,387653,377440,493322,533063,504891,640069,436173,614319,409904,821766,689068,512408,545582,639841,731360,373784,338815,650482,379221,533785,751432,817095,773316,712966,1085092,1778466,968252,884902,488526,733614,1873387,1503777,905964,1085214,585086,659366,797589,999792,931480,786188,1218504,816219,1247707,2626572,999226,752587,1511738,674251,35549404,11408508],"date":[1561640400,1561726800,1561986000,1562072400,1562158800,1562331600,1562590800,1562677200,1562763600,1562850000,1562936400,1563195600,1563282000,1563368400,1563454800,1563541200,1563800400,1563886800,1563973200,1564059600,1564146000,1564405200,1564491600,1564578000,1564664400,1564750800,1565010000,1565096400,1565182800,1565269200,1565355600,1565614800,1565701200,1565787600,1565874000,1565960400,1566219600,1566306000,1566392400,1566478800,1566565200,1566824400,1566910800,1566997200,1567083600,1567170000,1567515600,1567602000,1567688400,1567774800,1568034000,1568120400,1568206800,1568293200,1568379600,1568638800,1568725200,1568811600,1568898000,1568984400,1569243600,1569330000,1569416400,1569502800,1569589200,1569848400,1569934800,1570021200,1570107600,1570194000,1570453200,1570539600,1570626000,1570712400,1570798800,1571058000,1571144400,1571230800,1571317200,1571403600,1571662800,1571749200,1571835600,1571922000,1572008400,1572267600,1572354000,1572440400,1572526800,1572613200,1572876000,1572962400,1573048800,1573135200,1573221600,1573480800,1573567200,1573653600,1573740000,1573826400,1574085600,1574172000,1574258400,1574344800,1574431200,1574690400,1574776800,1574863200,1575036000,1575295200,1575381600,1575468000,1575554400,1575640800,1575900000,1575986400,1576072800,1576159200,1576245600,1576504800,1576591200,1576677600,1576764000,1576850400,1577109600,1577196000,1577368800,1577455200,1577714400,1577800800,1577973600,1578060000,1578319200,1578405600,1578492000,1578578400,1578664800,1578924000,1579010400,1579096800,1579183200,1579269600,1579615200,1579701600,1579788000,1579874400,1580133600,1580220000,1580306400,1580392800,1580479200,1580738400,1580824800,1580911200,1580997600,1581084000,1581343200,1581429600,1581516000,1581602400,1581688800,1582034400,1582120800,1582207200,1582293600,1582552800,1582639200,1582725600,1582812000,1582898400,1583157600,1583244000,1583330400,1583416800,1583503200,1583758800,1583845200,1583931600,1584018000,1584104400,1584363600,1584450000,1584536400,1584622800,1584709200,1584968400,1585054800,1585141200,1585227600,1585314000,1585573200,1585659600,1585746000,1585832400,1585918800,1586178000,1586264400,1586350800,1586437200,1586782800,1586869200,1586955600,1587042000,1587128400,1587387600,1587474000,1587560400,1587646800,1587733200,1587992400,1588078800,1588165200,1588251600,1588338000,1588597200,1588683600,1588770000,1588856400,1588942800,1589202000,1589288400,1589374800,1589461200,1589547600,1589806800,1589893200,1589979600,1590066000,1590152400,1590498000,1590584400,1590670800,1590757200,1591016400,1591102800,1591189200,1591275600,1591362000,1591621200,1591707600,1591794000,1591880400,1591966800,1592226000,1592312400,1592398800,1592485200,1592571600,1592830800,1592917200,1593003600,1593090000,1593176400,1593435600,1593522000,1593608400,1593694800,1594040400,1594126800,1594213200,1594299600,1594386000,1594645200,1594731600,1594818000,1594904400,1594990800,1595250000,1595336400,1595422800,1595509200,1595595600,1595854800,1595941200,1596027600,1596114000,1596200400,1596459600,1596546000,1596632400,1596718800,1596805200,1597064400,1597150800,1597237200,1597323600,1597410000,1597669200,1597755600,1597842000,1597928400,1598014800,1598274000,1598360400,1598446800,1598533200,1598619600,1598878800,1598965200,1599051600,1599138000,1599224400,1599570000,1599656400,1599742800,1599829200,1600088400,1600174800,1600261200,1600347600,1600434000,1600693200,1600779600,1600866000,1600952400,1601038800,1601298000,1601384400,1601470800,1601557200,1601643600,1601902800,1601989200,1602075600,1602162000,1602248400,1602507600,1602594000,1602680400,1602766800,1602853200,1603112400,1603198800,1603285200,1603371600,1603458000,1603717200,1603803600,1603890000,1603976400,1604062800,1604325600,1604412000,1604498400,1604584800,1604671200,1604930400,1605016800,1605103200,1605189600,1605276000,1605535200,1605621600,1605708000,1605794400,1605880800,1606140000,1606226400,1606312800,1606485600,1606744800,1606831200,1606917600,1607004000,1607090400,1607349600,1607436000,1607522400,1607608800,1607695200,1607954400,1608040800,1608127200,1608213600,1608300000,1608559200,1608645600,1608732000,1608818400,1609164000,1609250400,1609336800,1609423200,1609768800,1609855200,1609941600,1610028000,1610114400,1610373600,1610460000,1610546400,1610632800,1610719200,1611064800,1611151200,1611237600,1611324000,1611583200,1611669600,1611756000,1611842400,1611928800,1612188000,1612274400,1612360800,1612447200,1612533600,1612792800,1612879200,1612965600,1613052000,1613138400,1613484000,1613570400,1613656800,1613743200,1614002400,1614088800,1614175200,1614261600,1614348000,1614607200,1614693600,1614780000,1614866400,1614952800,1615212000,1615298400,1615384800,1615471200,1615557600,1615813200,1615899600,1615986000,1616072400,1616158800,1616418000,1616504400,1616590800,1616677200,1616763600,1617022800,1617109200,1617195600,1617282000,1617627600,1617714000,1617800400,1617886800,1617973200,1618232400,1618318800,1618405200,1618491600,1618578000,1618837200,1618923600,1619010000,1619096400,1619182800,1619442000,1619528400,1619614800,1619701200,1619787600,1620046800,1620133200,1620219600,1620306000,1620392400,1620651600,1620738000,1620824400,1620910800,1620997200,1621256400,1621342800,1621429200,1621515600,1621602000,1621861200,1621947600,1622034000,1622120400,1622206800,1622552400,1622638800,1622725200,1622811600,1623070800,1623157200,1623243600,1623330000,1623416400,1623675600,1623762000,1623848400,1623934800,1624021200,1624280400,1624366800,1624453200,1624539600,1624626000,1624885200,1624971600,1625058000,1625144400,1625230800,1625576400,1625662800,1625749200,1625835600,1626094800,1626181200,1626267600,1626354000,1626440400,1626699600,1626786000,1626872400,1626958800,1627045200,1627304400,1627390800,1627477200,1627563600,1627650000,1627909200,1627995600,1628082000,1628168400,1628254800,1628514000,1628600400,1628686800,1628773200,1628859600,1629118800,1629205200,1629291600,1629378000,1629464400,1629723600,1629810000,1629896400,1629982800,1630069200,1630328400,1630414800,1630501200,1630587600,1630674000,1631019600,1631106000,1631192400,1631278800,1631538000,1631624400,1631710800,1631797200,1631883600,1632142800,1632229200,1632315600,1632402000,1632488400,1632747600,1632834000,1632920400,1633006800,1633093200,1633352400,1633438800,1633525200,1633611600,1633698000,1633957200,1634043600,1634130000,1634216400,1634302800,1634562000,1634648400,1634734800,1634821200,1634907600,1635166800,1635253200,1635339600,1635426000,1635512400,1635771600,1635858000,1635944400,1636030800,1636117200,1636380000,1636466400,1636552800,1636639200,1636725600,1636984800,1637071200,1637157600,1637244000,1637330400,1637589600,1637676000,1637762400,1637935200,1638194400,1638280800,1638367200,1638453600,1638540000,1638799200,1638885600,1638972000,1639058400,1639144800,1639404000,1639490400,1639576800,1639663200,1639749600,1640008800,1640095200,1640181600,1640268000,1640613600,1640700000],"open":[30.61,27.9,27.42,27.26,27.06,28.61,28.71,28.3,27.58,27.49,29.61,28.5,27.93,26,26.21,26,27.6,30.64,28.83,28.12,27.03,28.51,28.88,27.86,29.35,29.64,28.11,27,27.64,29.65,29.67,26.5,26,26.44,25.64,26.74,27.52,28.02,28.96,30.01,29.99,29.6,30.64,31.25,29.8,30.51,30.6,32.29,31.55,31.18,30.94,28.02,26.56,27,26.09,25.91,25.26,24.86,24.83,24.59,26,28.08,25.53,23.57,21.25,20.22,21.48,20.71,19.49,20.44,19.29,19.4,19.29,18.22,18.98,18.69,18.12,18.52,18,18.37,18.38,18.65,18.4,18.58,18.42,18.78,19.56,20,20.28,22.83,24.4,23.31,23.23,22.32,24.49,27.72,27.15,28.04,26.38,27.84,30.31,29.38,30.05,33.87,33.47,34.55,31.01,28.29,29.73,28.96,31.03,31.44,34.01,32.35,33.22,36.46,37,36.52,37.46,36.39,35.37,35.05,38,36.85,41.57,46.61,45.68,42.93,36.94,35.48,35.17,32.86,32.55,35.08,34.35,34.61,33.67,31.26,33.61,34.67,34.9,35.33,34.21,32.38,33.95,34.45,34,35,34.26,34.03,34.77,34.63,35,34.93,35.46,35.39,35.04,36.83,35.05,34.37,34.11,34.59,34.94,35,34.99,34.99,33.44,32,32.28,29.41,32.22,32.19,32.01,30.76,28.15,27.05,27.37,27.54,22.21,21.9,19.68,18.18,15.63,16.17,21.41,26.17,24.99,24.96,24.92,26.1,26.98,26.65,27.77,24.61,24.55,23.64,25.54,25.09,27.6,28.8,28,27.7,26.52,27.42,26.65,26.67,27.62,28.6,29.8,32.345,32.64,31.83,30.79,29.93,29.24,30.76,30.82,32.75,33.85,33.31,33.36,32.55,29.67,30.76,33.01,35.2,34.7,35.09,34.86,35.02,35.83,36.42,31.34,29.64,28.84,29.03,28.9,28.45,29.77,29.54,30,28.32,29.06,27.86,31.75,31.69,31.17,32.75,31.63,33.59,32.16,32.61,34.4,33.62,32.54,32.63,30.78,29.97,29.35,30.19,31.65,32.26,32.06,29.95,29,30.42,30.42,31.1,32.06,29.99,30.7,30.45,30.26,32.26,31.38,28.55,29.76,28.5,26.5,27.79,27.49,27.92,28.6,28.82,28.57,28.98,29,28.99,29.67,29.28,28.86,28.42,28.3,28.95,29.4,29.27,29.32,29.66,29.75,27.8,28.36,28.74,28.68,32.01,32.93,33.4,33.9,36.72,37.27,37,38.98,41.72,39.91,39.98,38.23,37.13,37.25,36.93,37.68,37.77,39.29,36.7,40.3,39.88,40.8,39.15,40.32,39.82,39.74,38.27,39.24,41.26,39.73,39.38,39.31,40.27,38.77,39.66,39.25,38.63,38.84,39.02,39.04,39.84,40.17,41.35,40.55,40.8,40.51,41,43.95,43.52,43.49,43.34,43,43.15,44.45,46.98,47.23,48.96,49.3,50.99,51.02,49.06,51.17,52.34,53.07,57.17,56.49,58.2,62.85,61.16,60.82,61.64,64.82,63.93,65.87,67.91,69.58,70.44,69.39,68.36,69.81,71.12,63.22,64.67,64.87,65.14,66,68.89,68.64,65,69.07,69.81,69.53,68.29,65.49,67.46,65.48,60.53,56.84,56.64,57.01,58.94,63.5,63.47,65,68.93,72.82,71.28,69.7,68.48,67.66,64.35,63.65,66,66.68,64.91,65.85,67.86,65.4,72.47,69.28,65.72,63.48,63,62.89,60.81,65.5,70.71,70.38,70.28,70.04,67.14,68.6,64.02,70.41,68.12,66.34,60.35,63.3,60.22,56.85,59.37,62.49,60.22,57.31,57.51,57.04,57.54,54.32,54.19,54.93,55.76,55.87,54.39,55.01,53.42,55.27,56.16,55.14,55.85,55.05,56.35,54.61,56.5,55.35,53.8,52.56,49.21,47.47,44.94,48.73,49.67,50.88,53.15,54.33,55,55.12,58.8,58.19,57.54,58.11,58.92,58.16,59.72,60.5,59.2,59.2,58.25,62,62.68,61.6,61.6,64.06,63.6,61.92,62.61,61.37,61.72,62.87,60.13,59.81,59.56,60,59.66,61.045,61.39,63.9,64.11,64.03,63,64.3,63.62,62.83,62.87,58.53,60.02,57.94,57.6,61.36,61.43,62.07,60.56,55.91,54.06,55.47,54.21,53.64,51.515,52.42,53.72,56.19,53.9,53.46,52.56,51.98,50.7,49.67,49.04,49.77,48.31,47.64,49.7,49.28,49.9,50.47,49.25,50.79,48.59,50.04,51.02,51.11,51.14,52.385,49.82,51.44,50.75,51.03,48.96,48.49,49.96,50.87,49.64,50.52,51.67,49.44,48.69,49.99,50.29,47.62,46.86,48.44,47.37,45.66,45,44.75,43.89,46.7,46.64,49.04,49.84,47.96,48.03,47.62,45.44,46.13,47.54,48.6,49,49.08,50.51,49.21,51.55,50.7,49.92,52.12,53.53,51.87,50.73,49.8,47.75,48.44,47.95,46.97,46.07,44,42.65,41.55,40.62,39.84,40.4,37.66,40.96,39.68,40.03,38.55,39.85,39.47,39.86,37.22,36.03,37.66,38.05,38.81,36.54,41.93,41.47,42.02,38.3,12.64,12.17],"high":[31.2,28,27.865,27.55,29.1,29.15,28.98,28.42,27.95,31.637,29.61,28.725,27.93,26.56,27,28.15,30.8,30.663,30.832,28.56,28.94,29.47,29,29.5,32.812,30.593,28.11,28.22,29.58,30.49,29.99,27.38,27.09,26.44,27.14,28.32,29.49,29.11,30,30.5,30.6,30.98,31.78,31.91,30.92,31.5,32.94,32.295,32.2,32.22,31.113,29.02,27.5,27.286,26.53,26.39,25.705,25.305,25.68,26.43,28.25,28.363,26.05,23.813,22.46,22.24,22.68,21.11,20.23,20.99,19.95,19.85,19.294,19.45,19.74,18.81,18.98,18.99,19,18.5,18.91,18.92,19,18.95,19.43,19.67,20.805,20.69,22.91,24.42,25.115,23.89,23.61,25.425,27.74,28.5,28.341,28.261,27.93,28.92,30.31,31.14,33.3,35.67,34.99,34.88,31.8,30.29,29.973,31.6,32.05,34.07,34.971,33.299,38.56,39.64,37.592,38.38,37.92,38.15,36.98,38.99,38.234,42.41,48.36,47.445,46.68,43.01,37.304,36.22,35.17,33.47,35.81,35.55,35.25,34.809,34.97,34,35.21,35.09,35.5,35.63,34.45,34.9,35,35.13,35.21,35.057,35.08,35.468,34.94,35.35,35.2,35.49,35.97,35.9,36.26,37.6,35.07,34.98,35.26,36.32,35.93,35.15,36.14,35.99,33.688,34.375,33.6,32.195,33.65,33.42,34.45,31.18,30.23,27.84,28.55,27.95,23.47,23.2,20.27,19.37,19.25,21.06,29.64,26.17,25.49,26.2,27.75,27.86,27.595,29,28.78,25.535,26.94,25,26.69,27.2,28.9,29.4,29.58,28.19,27.03,27.66,28.64,27.52,28.75,30.772,31.19,32.675,32.845,32.43,32,30.35,30.26,31.58,32.66,34.305,34.37,34.195,34.92,32.905,30.93,32.49,35.05,35.93,35.175,35.73,35.29,36.55,36.06,36.5,32.46,30.035,29.25,30.21,29.44,29.79,30.09,30.76,30.39,28.85,29.27,31.17,32.3,32.91,32.94,33.65,33.5,34,33.26,34.41,34.6,34.07,33.26,32.77,30.98,30.89,30.92,31.48,32.58,32.86,32.06,30.05,30.835,30.87,31.965,32.06,32.06,31.27,31.98,31,32.58,32.75,31.38,29.89,29.9,28.85,27.74,28.03,28.22,28.785,29.15,30.15,30.25,29.72,29.22,29.88,29.89,29.69,29.54,28.84,29.2,29.45,29.76,30.19,29.95,30.21,29.96,28.85,29.18,29.48,32.79,34.14,34.25,35.14,36.9,37.47,38.51,38.56,42.63,41.86,40.32,40.41,39,37.66,37.26,37.92,38.46,39.78,40.41,40.12,40.43,40.88,40.8,40.07,40.42,40.739,40.03,39.64,41.51,41.49,40.23,39.73,41.03,40.7,39.71,40.5,39.67,39.68,39.02,39.12,40.13,41.6,42.19,41.35,41.92,41.64,41.04,44.03,43.95,45.28,44.28,44.46,44.01,44.65,46.57,47.15,48.64,50.09,51.535,52.41,51.02,50.77,52.3,53.58,56.75,58.67,58.93,62.5,64.315,61.645,61.72,64.57,66.38,65.88,68.275,69.55,70.56,70.715,69.76,70.98,71.56,71.84,65.88,65.945,65.8,66.63,68.93,69.59,69.115,70.01,70,69.88,71.4,68.38,69.58,68.505,65.91,60.87,57.26,57.44,57.97,63.45,64.2,64.75,68.32,72.73,73.5,72.39,69.99,71.25,69.21,65.477,64.48,69.26,68.67,66.5,68.3,69.485,71.76,72.82,71.01,67.38,65.02,63,64.29,65.5,69.9,72.97,72.075,71.64,70.71,68.99,68.669,68,71,69.19,66.93,63.47,63.69,60.485,60.11,62,63.13,60.5,59.69,59.14,58.46,58.08,54.55,55.5,58.34,57.07,56.12,56.21,56.475,55.42,57.14,56.505,56.01,56.155,56.77,56.365,56.55,56.55,55.35,54.86,52.61,50.65,47.63,49.93,51.28,51.86,53.94,54.38,56.29,55.91,57.6,59.61,58.315,58.23,59.28,58.92,59.66,60.68,60.886,59.72,59.81,63.19,63.32,63.19,63.26,64.14,64.18,63.68,64.61,64.03,62.695,63.78,63.35,60.625,60.8,60.63,60.46,60.56,61.8,64.05,64.53,64.4,65.33,64.37,64.71,65.09,64.21,63.22,59.97,61.27,59.22,61.32,61.92,62.71,62.07,60.95,56.41,56.135,55.985,54.21,53.96,53.3,54.08,57.44,56.19,55.16,53.46,53.33,52.22,52.11,50.65,49.73,50.44,48.95,49.72,50.32,50.01,50.57,50.94,51.05,51.64,50.32,51.38,51.31,52.06,51.77,52.385,51.96,51.61,51.21,51.2,49.48,49.37,52.19,51.96,51.04,50.76,51.67,49.72,50.73,50.85,50.87,48.675,48.245,48.44,48.32,46.51,46.607,45.18,46.94,47.82,48.64,50.175,50,48.44,48.89,48.309,46.8,47.02,48.715,50.03,49.45,50.7,50.59,51.94,51.69,51.57,51.98,53.57,53.53,51.87,51.55,50.47,48.4,48.84,48.71,47.205,46.74,45.13,43.958,41.55,40.995,40.59,40.42,41.04,42.97,40.775,40.03,39.57,40.68,40.91,40.43,38.007,38.26,39.01,38.83,39.65,43.045,42.34,43.14,42.02,41.59,13.15,12.9],"low":[25.36,25.55,26.09,25.5,27.06,27.25,27.905,27.3,26.84,26.98,28.281,27.097,25.41,25.61,25.51,24.056,27.6,28.25,28,26.01,27,28.03,27.02,27.43,29.35,27.7,26.64,26.71,27.276,28.78,25.69,25.78,25.749,25.315,25.64,26.58,27.44,27.85,28.51,29.655,28.57,29.43,30.045,29.26,27.59,29.1,30.49,31.15,30.65,30.86,28.09,26.245,26.08,26.004,25.33,24.51,24.67,24.43,24.33,24.48,26,25.11,23.21,21.2,19.71,19.28,20.75,19.33,19.01,19.17,18.51,18.68,17.61,18.16,18.32,18.05,18.06,17.69,17.746,17.84,18.292,18.34,18.19,18.34,17.73,18.65,19.52,19.81,20.2,22.584,21.64,21.91,21.92,22.32,24.22,26.495,24.039,26.2,25.905,27.35,27.38,28.75,30,32.59,33.47,30.59,28.09,28.04,28.75,28.95,30.3,30.952,31.91,32.35,33.095,36.46,36.12,36.52,35.29,34.92,33.62,35.05,36,36.75,40.16,44.887,42.71,35.6,35.02,34.594,32.01,31.69,31.6,34.17,33.51,32.73,30.95,29.74,33.07,34,34.47,34,31.28,32.24,33.01,33.87,34,33.67,33.23,33.01,33.25,34.2,34.18,34.48,34.79,34.85,34.951,34.57,33.77,33.9,34.11,32.9,34.55,33.84,34.29,32.14,31.61,31.91,30.43,29.06,31.26,31.065,30.82,29.53,28.02,24.64,25.9,23.805,20.25,18.88,17.05,16.525,14.23,15.57,20.6,22.765,22.78,23.27,24.72,25.709,25.51,26.38,24.78,23.74,21.64,22.46,24.09,23.191,26.324,26.365,26.81,26.05,25.24,26.3,26.51,26.21,27.02,28.6,29.15,31.39,30.205,30.39,30.51,28.6,28.37,30.09,30.6,32.225,33.16,32.11,32.39,29.56,29.09,29.7,33.01,34.5,33.77,33.66,34.33,34.504,34,34.92,28.87,28.51,27.5,28.61,27.212,28.053,29.344,29.4,29.01,27.6,27.52,27.86,30.59,31.48,30.56,31.51,30.67,32.33,31.4,32.3,32.58,32.24,31.98,30.1,29.59,29.45,29.062,30,31.239,31.02,29.8,27.53,28.56,29.56,30.235,30.82,30.15,29.12,30.19,29.81,30.26,31.28,28.81,28.43,26.75,26.77,26.17,26.81,27,27.88,28.4,28.18,28.39,28.09,28.23,28.326,28.87,28.75,28.11,27.48,27.85,28.7,29.01,28.88,29.2,28.74,27.47,27.55,27.74,27.56,28.33,31.95,32.511,33.01,33.9,36.29,37.11,36.98,38.28,39.271,37.99,38.57,37.61,36.26,36.46,36.25,37,37.6,38.53,36.197,39.01,39.045,38.85,38.67,38.93,38.464,38.26,37.83,38.98,38.75,38.98,38.8,39.31,38.81,38.13,39.485,38.38,38.55,37.29,37.77,39.02,39.41,40.13,39.02,39.77,39.81,39.57,40.82,41.43,43.52,42.93,43.07,42.864,43.15,44.25,45.6,46.9,48.24,48.9,50.11,48.49,48.55,50.67,52,53.05,55.56,56.07,58.14,60.89,59.06,60.35,60.34,64.23,63.64,65.2,66.93,68.51,68.579,66.2,67.89,67.655,63.08,62.738,63.39,64.305,62.94,65.09,67.57,65.4,64.693,66.9,68.395,67.479,65.88,64.7,62.81,60.28,55.19,55.34,54.35,55.23,58.62,62.32,62.53,64.47,67.81,70.66,68.25,66.33,66.74,64.51,63.615,62.02,64.85,64.86,62.66,65.03,64.1,64.41,69.2,66.08,63.74,59.65,57.71,59.285,60.04,65.5,69.08,69,69.25,67.22,66.28,63.31,63.34,66.16,65.34,61.27,60.2,60.26,57,56.31,59.22,59.04,58.01,57.31,55.88,56.385,54.015,53.56,52.96,54.93,54.23,53.99,54.13,53.4,53.11,54.23,53.945,54.49,54.32,54.55,54.385,54.61,53.81,53.01,52.28,48.68,47.64,45.77,44.94,48.415,49.65,50.88,51.8,54.085,53.74,53.98,57.57,55.8,56.62,57.43,56.54,57.04,58.6,58.013,57.14,57.45,57.68,60.64,60.64,60.84,61.35,61.73,61.3,61.88,61,59.83,61.29,60,58.96,58.38,58.58,57.35,58.63,59.64,60.96,62.8,62.89,63.49,62.7,63.67,63.61,62.28,58.58,57.52,58.91,57.38,57.575,59.15,60.55,60.3,56.12,53.3,53.38,54.35,52.95,52.16,51.515,52.42,52.575,53.79,53.24,52.1,51.27,50.31,49.95,48.525,48.18,48.051,46.97,46.68,49.175,48.63,49.37,48.63,49.01,48.24,48.59,49.86,49.84,51.095,50.59,49.68,49.56,49.83,49.933,48.2,47.69,47.1,49.325,48.57,49.455,49.87,49,48.21,48.03,49.44,47.46,46.73,44.89,46.48,45.94,44.72,44.64,43.5,43.41,45.945,46.5,48.81,47.83,47.25,47.04,45.27,45.43,45.33,46.94,48.46,48.53,48.78,49.32,49.21,49.9,49.145,49.87,51.02,51.16,50.49,49.25,47.71,46.95,47.405,47.06,45.816,44.61,42.51,40.57,39.335,40.07,37.94,37.64,37.66,39.53,38.86,38.13,37.96,39.575,39.31,37.15,36.01,35.565,37.2,36.16,36.72,36.054,40.41,41.02,38.07,38.13,11.2,12.06],"close":[27.55,26.97,27.37,27.04,28.61,28.99,28.2,27.36,27.6,29.77,28.62,27.84,25.94,26.12,26,27.51,30.34,28.83,28.12,26.79,28.37,28.69,27.78,29.35,29.69,28.29,26.9,27.88,29.47,29.82,26.88,26.19,26.76,25.89,26.76,27.46,28.05,28.66,29.82,29.8,29.31,30.49,31.26,29.61,30.71,30.48,32.38,31.48,31.32,30.93,28.35,26.55,26.95,26.1,25.91,25.38,24.86,24.75,24.53,26.27,27.605,25.46,23.39,21.24,20.13,21.47,20.9,19.57,20.17,19.43,19.63,19.11,18.35,18.75,18.53,18.12,18.62,17.96,18.51,18.21,18.63,18.4,18.48,18.51,18.72,19.44,20,20.26,22.61,24.15,23.08,23.21,22.16,24.42,27.06,26.75,27.96,26.28,27.57,28.26,29.07,30.29,33.29,33.54,34,31.04,28.29,29.84,29,31.14,30.56,33.92,32.2,33.02,36.26,36.93,36.73,37.45,36.5,35.16,34.94,38.46,36.75,41.54,46.63,45.5,43,36.84,35.44,35.05,33.22,32.22,34.85,34.61,34.18,33.56,31.02,33.61,34.58,34.51,35,34.4,32.23,34.16,34.39,34.13,34.8,34.26,34.24,34.93,34.49,34.81,34.5,35,35.4,34.995,36.23,34.84,34.65,34.05,34.65,34.07,35.17,34.99,36.14,33.25,31.94,32.7,30.44,31.88,32.21,32.59,31.06,29.99,28.92,26.98,28.48,23.88,20.28,23.06,17.65,16.82,16.11,20.5,26.62,24.19,25.48,24.7,27.39,26.67,26.67,29,25.08,24.74,22.22,24.995,24.42,26.93,28.38,27.18,29.04,26.54,26.54,27.39,27.62,26.95,28.56,29.7,31.09,31.74,30.6,31.78,30.53,28.97,29.99,30.85,32.27,33.08,34.04,32.98,32.83,30.78,30.6,32.19,34.82,34.5,34.9,34.73,35,35.32,35.69,35.11,29.33,28.88,29,28.86,27.77,29.08,29.84,29.82,29.19,27.79,28.67,31.11,31.71,31.73,32.48,31.51,33.15,32.62,32.96,34.32,33.2,32.59,32.61,30.34,29.76,29.67,30.42,31.47,32.23,31.58,29.83,28.05,30.53,30.68,31.53,31.73,30.19,30.885,30.68,30.25,32.37,31.38,28.98,29.71,28.14,27.2,27.4,27.7,27.85,28.38,28.48,28.39,28.89,29.11,28.53,29.76,29.17,29.13,28.26,28.17,28.8,29.39,29.13,29.28,29.59,29.86,27.62,28.38,28.29,28.92,32.09,33.15,33.09,33.56,36.46,36.99,37.38,38.46,42.19,39.66,40.02,38.65,37.77,36.66,36.84,37.1,37.52,39.6,39.6,39.77,39.35,40.31,38.9,39.34,39.87,39.73,38.43,39.2,40.97,39.53,39.29,39.11,40.21,39.66,39.69,39.76,38.63,39.01,38.38,38.57,39.88,40.02,40.99,39.375,40.35,40.15,40.97,43.05,43.52,44.33,43.54,43.35,43.7,44.23,46.44,46.98,48.47,49.13,50.24,51.13,48.85,50.51,52.19,53.1,56.67,56.86,57.75,61.35,61.2,60.99,61.54,64.41,64.89,65.75,67.91,69.09,69.5,69.48,67.62,70.07,71.11,63.64,65.05,64.23,64.81,65.51,68.58,68.64,65.68,69.73,68.61,69.38,67.71,66.44,69.48,65.79,62.33,55.47,56.3,56.76,57.43,63.01,62.98,64.51,68.28,72.35,70.85,68.87,67.27,67.36,64.98,64.72,63.85,66.68,65.67,65.94,67.41,65.13,70.68,71.91,66.17,63.9,62.52,62.22,59.48,64.9,69.72,71.22,70.94,69.89,68.05,68.62,63.47,67.66,69.11,65.79,61.27,63.14,60.82,57.1,59.12,61.6,59.36,58.99,57.75,56.06,58.12,54.49,53.96,54.6,55.75,54.95,55.12,55.51,54.12,55.31,55.9,54.47,55.82,55.32,56.23,55.27,55.92,55.37,54,52.94,49.59,48.03,46.47,49.13,49.48,50.72,53.66,54.13,55.73,54.97,57.22,57.9,56.96,57.68,58.63,57.99,59.2,60.37,59.41,58.81,57.96,61.95,62.33,61.35,62.3,63.93,63.74,62.47,63.18,62.63,61.33,63.13,60.34,59.35,59.5,60.45,59.39,60.12,60.96,63.61,63.85,64.24,64.11,63.95,64.17,63.78,62.73,58.73,59.34,59.18,57.41,61.11,61.6,61.65,60.6,56.31,53.74,55.37,54.38,53.45,52.33,52.79,52.83,56.13,54.1,53.39,52.23,52.13,50.84,50.12,49.48,49.54,48.63,47.08,49.03,49.28,49.85,50.32,49.21,50.48,48.59,50.11,50.64,51.18,51.62,51.68,50.01,50.87,50.35,50.91,48.73,48.46,49.36,52.12,49.22,50.18,49.94,49.9,48.57,50.44,50.1,47.62,46.87,47.74,47.07,46.34,44.91,44.75,44.11,46.64,46.64,48.55,49.35,47.98,47.86,47.17,45.4,46.13,47,48.45,49.08,48.93,50.5,49.38,51.83,51.05,50.01,51.46,53.41,51.62,51.01,49.31,47.88,47.88,48.16,47.25,46.1,44.89,42.65,40.63,40.94,40.74,39.55,38.04,40.5,39.56,40.03,38.62,39.35,39.91,40.28,37.22,36.19,38.03,38.16,38.78,37.05,42.65,41.44,42.36,38.38,40.62,11.38,12.805],"lastOpen":12.170000076293945,"lastHigh":12.899999618530273,"lastLow":12.0600004196167,"lastClose":12.805000305175781,"lastVolume":11408508,"lastDate":20211228,"prevClose":11.380000114440918,"afterClose":null,"afterChange":null,"patterns":[{"kind":1,"strength":3830.094,"status":2,"bounces":0,"x1":0,"y1":150,"x2":600,"y2":150,"x3":0,"y3":0,"x4":0,"y4":0,"ticker":""},{"kind":2,"strength":826.8738,"status":2,"bounces":4,"x1":186,"y1":68,"x2":600,"y2":128,"x3":0,"y3":0,"x4":0,"y4":0,"ticker":""},{"kind":3,"strength":801.1271,"status":-2,"bounces":2,"x1":117,"y1":150,"x2":600,"y2":190,"x3":0,"y3":0,"x4":0,"y4":0,"ticker":""}],"patternsMinRange":10,"patternsMaxRange":80};                                        data.instrument = 'stock';                                        data.premarket = false;                                        data.aftermarket = false;                                        Quote.create(data);                                    })();                                  </script><script type="text/javascript">                                    var chartConfig = {          "layout":"1h1v",          "width": 1280,          "barWidth": 3,          "barMargin": 1,          "height": 400,          "scrollable": false,          "ideas": false,          editors: ['publish'],          "charts":[{                "height":400,                "timeframe":"d",                "scale":"linear",                "ticker":"BBIO",                "instrument":"stock",                "refreshData": 180*1000,                "panes": []}]        };                                    var taConfig = JSON.parse(JSON.stringify(FinvizSettings.TA));                                                                        checkSmallDisplay(chartConfig);                                                                        var FinvizQuoteTypeCurrent = taConfig.style;                                    var mergeChartAndTAConfig = FLibs.Charts.convertTa.mergeChartAndTAConfig;                                    mergeChartAndTAConfig(chartConfig, taConfig);                                    var minHeight = 9 /* some browser padding */ + 400 + taConfig.indicators.length * 120 + (chartConfig.ideas ? 40 : 0);                                    document.getElementById('chart').style.minHeight = minHeight + 'px';                                    window.globalChartConfig = chartConfig                                  </script></div><div class="content" data-testid="quote-data-content"><div class="fv-container"><table width="100%"><tr><td align="center" valign="top"><table width="100%" cellpadding="3" cellspacing="0" bgcolor="#ffffff" class="fullview-title"><tr><td align="center"><a href="quote.ashx?t=BBIO&ty=c&ta=1&p=d" class="fullview-ticker" id="ticker">BBIO</a> <span class="body-table">[NASD]</span></td></tr><tr><td align="center"><a href="https://www.bridgebio.com" target="_blank" class="tab-link"><b>BridgeBio Pharma, Inc.</b></a></td></tr><tr><td align="center" class="fullview-links"><a href="screener.ashx?v=111&f=sec_healthcare" class="tab-link">Healthcare</a> | <a href="screener.ashx?v=111&f=ind_biotechnology" class="tab-link">Biotechnology</a> | <a href="screener.ashx?v=111&f=geo_usa" class="tab-link">USA</a></td></tr></table><table width="100%" cellpding="0" cellspacing="0" class="fullview-links"><td align="left" width="80%"></td><td align="right" width="20%"><a class="tab-link" href="#statements">statements</a></td></tr></table></tr></td></table><table width="100%" cellpadding="3" cellspacing="0" border="0" class="snapshot-table2"><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Major index membership] offsetx=[10] offsety=[20] delay=[300]">Index</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Earnings (ttm)] offsetx=[10] offsety=[20] delay=[300]">P/E</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Diluted EPS (ttm)] offsetx=[10] offsety=[20] delay=[300]">EPS (ttm)</td><td width="8%" class="snapshot-td2" align="left"><b>-3.90</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Insider ownership] offsetx=[10] offsety=[20] delay=[300]">Insider Own</td><td width="8%" class="snapshot-td2" align="left"><b>3.50%</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Shares outstanding] offsetx=[10] offsety=[20] delay=[300]">Shs Outstand</td><td width="8%" class="snapshot-td2" align="left"><b>146.66M</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Week)] offsetx=[10] offsety=[20] delay=[300]">Perf Week</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-73.32%</span></b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Market capitalization] offsetx=[10] offsety=[20] delay=[300]">Market Cap</td><td width="8%" class="snapshot-td2" align="left"><b>1.58B</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Forward Price-to-Earnings (next fiscal year)] offsetx=[10] offsety=[20] delay=[300]">Forward P/E</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS estimate for next year] offsetx=[10] offsety=[20] delay=[300]">EPS next Y</td><td width="8%" class="snapshot-td2" align="left"><b>-3.81</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Insider transactions (6-Month change in Insider Ownership)] offsetx=[10] offsety=[20] delay=[300]">Insider Trans</td><td width="8%" class="snapshot-td2" align="left"><b>-0.28%</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Shares float] offsetx=[10] offsety=[20] delay=[300]">Shs Float</td><td width="8%" class="snapshot-td2" align="left"><b>97.54M</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Month)] offsetx=[10] offsety=[20] delay=[300]">Perf Month</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-72.07%</span></b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Income (ttm)] offsetx=[10] offsety=[20] delay=[300]">Income</td><td width="8%" class="snapshot-td2" align="left"><b>-535.30M</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Earnings-to-Growth] offsetx=[10] offsety=[20] delay=[300]">PEG</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS estimate for next quarter] offsetx=[10] offsety=[20] delay=[300]">EPS next Q</td><td width="8%" class="snapshot-td2" align="left"><b>-0.87</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Institutional ownership] offsetx=[10] offsety=[20] delay=[300]">Inst Own</td><td width="8%" class="snapshot-td2" align="left"><b>96.00%</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Short interest share] offsetx=[10] offsety=[20] delay=[300]">Short Float</td><td width="8%" class="snapshot-td2" align="left"><b>11.89%</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Quarter)] offsetx=[10] offsety=[20] delay=[300]">Perf Quarter</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-77.44%</span></b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Revenue (ttm)] offsetx=[10] offsety=[20] delay=[300]">Sales</td><td width="8%" class="snapshot-td2" align="left"><b>57.00M</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Sales (ttm)] offsetx=[10] offsety=[20] delay=[300]">P/S</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">27.77</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS growth this year] offsetx=[10] offsety=[20] delay=[300]">EPS this Y</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-53.40%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Institutional transactions (3-Month change in Institutional Ownership)] offsetx=[10] offsety=[20] delay=[300]">Inst Trans</td><td width="8%" class="snapshot-td2" align="left"><b>-2.06%</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Short interest ratio] offsetx=[10] offsety=[20] delay=[300]">Short Ratio</td><td width="8%" class="snapshot-td2" align="left"><b>8.42</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Half Year)] offsetx=[10] offsety=[20] delay=[300]">Perf Half Y</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-80.84%</span></b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Book value per share (mrq)] offsetx=[10] offsety=[20] delay=[300]">Book/sh</td><td width="8%" class="snapshot-td2" align="left"><b>-5.07</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Book (mrq)] offsetx=[10] offsety=[20] delay=[300]">P/B</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS growth next year] offsetx=[10] offsety=[20] delay=[300]">EPS next Y</td><td width="8%" class="snapshot-td2" align="left"><b>3.20%</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Assets (ttm)] offsetx=[10] offsety=[20] delay=[300]">ROA</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-58.50%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Analysts' mean target price] offsetx=[10] offsety=[20] delay=[300]">Target Price</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">81.20</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Year)] offsetx=[10] offsety=[20] delay=[300]">Perf Year</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-83.63%</span></b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Cash per share (mrq)] offsetx=[10] offsety=[20] delay=[300]">Cash/sh</td><td width="8%" class="snapshot-td2" align="left"><b>4.31</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price to cash per share (mrq)] offsetx=[10] offsety=[20] delay=[300]">P/C</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">2.64</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Long term annual growth estimate (5 years)] offsetx=[10] offsety=[20] delay=[300]">EPS next 5Y</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Equity (ttm)] offsetx=[10] offsety=[20] delay=[300]">ROE</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">138.60%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[52-Week trading range] offsetx=[10] offsety=[20] delay=[300]">52W Range</td><td width="8%" class="snapshot-td2" align="left"><b><small>11.20 - 73.50</small></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Year To Date)] offsetx=[10] offsety=[20] delay=[300]">Perf YTD</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-84.00%</span></b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Dividend (annual)] offsetx=[10] offsety=[20] delay=[300]">Dividend</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price to Free Cash Flow (ttm)] offsetx=[10] offsety=[20] delay=[300]">P/FCF</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Annual EPS growth past 5 years] offsetx=[10] offsety=[20] delay=[300]">EPS past 5Y</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Investment (ttm)] offsetx=[10] offsety=[20] delay=[300]">ROI</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-88.40%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 52-Week High] offsetx=[10] offsety=[20] delay=[300]">52W High</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-82.58%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Beta] offsetx=[10] offsety=[20] delay=[300]">Beta</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Dividend yield (annual)] offsetx=[10] offsety=[20] delay=[300]">Dividend %</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quick Ratio (mrq)] offsetx=[10] offsety=[20] delay=[300]">Quick Ratio</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">6.70</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Annual sales growth past 5 years] offsetx=[10] offsety=[20] delay=[300]">Sales past 5Y</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Gross Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]">Gross Margin</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">97.30%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 52-Week Low] offsetx=[10] offsety=[20] delay=[300]">52W Low</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">14.33%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Average True Range (14)] offsetx=[10] offsety=[20] delay=[300]">ATR</td><td width="8%" class="snapshot-td2" align="left"><b>4.67</b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Full time employees] offsetx=[10] offsety=[20] delay=[300]">Employees</td><td width="8%" class="snapshot-td2" align="left"><b>385</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Current Ratio (mrq)] offsetx=[10] offsety=[20] delay=[300]">Current Ratio</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">6.70</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quarterly revenue growth (yoy)] offsetx=[10] offsety=[20] delay=[300]">Sales Q/Q</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-71.60%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Operating Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]">Oper. Margin</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Relative Strength Index] offsetx=[10] offsety=[20] delay=[300]">RSI (14)</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">22.93</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Volatility (Week, Month)] offsetx=[10] offsety=[20] delay=[300]">Volatility</td><td width="8%" class="snapshot-td2" align="left"><b><small>9.36% 7.69%</small></b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Stock has options trading on a market exchange] offsetx=[10] offsety=[20] delay=[300]">Optionable</td><td width="8%" class="snapshot-td2" align="left"><b>Yes</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Total Debt to Equity (mrq)] offsetx=[10] offsety=[20] delay=[300]">Debt/Eq</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quarterly earnings growth (yoy)] offsetx=[10] offsety=[20] delay=[300]">EPS Q/Q</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-8.40%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Net Profit Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]">Profit Margin</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Relative volume] offsetx=[10] offsety=[20] delay=[300]">Rel Volume</td><td width="8%" class="snapshot-td2" align="left"><b>51.11</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Previous close] offsetx=[10] offsety=[20] delay=[300]">Prev Close</td><td width="8%" class="snapshot-td2" align="left"><b>11.38</b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Stock available to sell short] offsetx=[10] offsety=[20] delay=[300]">Shortable</td><td width="8%" class="snapshot-td2" align="left"><b>Yes</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Long Term Debt to Equity (mrq)] offsetx=[10] offsety=[20] delay=[300]">LT Debt/Eq</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Earnings date<br><br>BMO = Before Market Open<br>AMC = After Market Close] offsetx=[10] offsety=[20] delay=[300]">Earnings</td><td width="8%" class="snapshot-td2" align="left"><b>Nov 04 BMO</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Dividend Payout Ratio (ttm)] offsetx=[10] offsety=[20] delay=[300]">Payout</td><td width="8%" class="snapshot-td2" align="left"><b>-</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Average volume (3 month)] offsetx=[10] offsety=[20] delay=[300]">Avg Volume</td><td width="8%" class="snapshot-td2" align="left"><b>1.38M</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Current stock price] offsetx=[10] offsety=[20] delay=[300]">Price</td><td width="8%" class="snapshot-td2" align="left"><b>12.81</b></td></tr><tr class="table-dark-row"><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Analysts' mean recommendation (1=Buy 5=Sell)] offsetx=[10] offsety=[20] delay=[300]">Recom</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">1.80</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 20-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]">SMA20</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-66.24%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 50-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]">SMA50</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-70.67%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 200-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]">SMA200</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-red">-75.64%</span></b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Volume] offsetx=[10] offsety=[20] delay=[300]">Volume</td><td width="8%" class="snapshot-td2" align="left"><b>11,408,508</b></td><td width="7%" class="snapshot-td2-cp" align="left" title="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (today)] offsetx=[10] offsety=[20] delay=[300]">Change</td><td width="8%" class="snapshot-td2" align="left"><b><span class="is-green">12.52%</span></b></td></tr></table></td></tr></table><tr><td><table width="100%" cellpadding="0" cellspacing="0" border="0"><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px"></td></tr><tr><td align="center"><div id="IC_D_3x6_1"></div></td></tr><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px"></td></tr><tr><td><table width="100%" class="fullview-ratings-outer" cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Dec-27-21</td><td width="200" align="left"><b>Reiterated</b></td><td width="250" align="left">SVB Leerink</td><td width="250" align="left">Outperform</td><td width="150" align="left">$66 &rarr; $24</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Dec-27-21</td><td width="200" align="left"><b>Reiterated</b></td><td width="250" align="left">Mizuho</td><td width="250" align="left">Buy</td><td width="150" align="left">$86 &rarr; $25</td></tr></table></td></tr><tr class="body-table-rating-upgrade"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-upgrade"><td width="120" align="left">Sep-10-21</td><td width="200" align="left"><b>Upgrade</b></td><td width="250" align="left">BofA Securities</td><td width="250" align="left">Neutral &rarr; Buy</td><td width="150" align="left">$75</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">May-21-21</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">UBS</td><td width="250" align="left">Buy</td><td width="150" align="left">$80</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Mar-22-21</td><td width="200" align="left"><b>Reiterated</b></td><td width="250" align="left">Goldman</td><td width="250" align="left">Buy</td><td width="150" align="left">$83 &rarr; $91</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Feb-22-21</td><td width="200" align="left"><b>Resumed</b></td><td width="250" align="left">JP Morgan</td><td width="250" align="left">Overweight</td><td width="150" align="left">$78</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Feb-09-21</td><td width="200" align="left"><b>Resumed</b></td><td width="250" align="left">Goldman</td><td width="250" align="left">Buy</td><td width="150" align="left">$83</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jan-11-21</td><td width="200" align="left"><b>Reiterated</b></td><td width="250" align="left">H.C. Wainwright</td><td width="250" align="left">Buy</td><td width="150" align="left">$64 &rarr; $87</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Dec-10-20</td><td width="200" align="left"><b>Reiterated</b></td><td width="250" align="left">H.C. Wainwright</td><td width="250" align="left">Buy</td><td width="150" align="left">$53 &rarr; $64</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jun-25-20</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">BofA/Merrill</td><td width="250" align="left">Neutral</td><td width="150" align="left">$38</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">May-19-20</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">BTIG Research</td><td width="250" align="left">Buy</td><td width="150" align="left">$49</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Apr-13-20</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">H.C. Wainwright</td><td width="250" align="left">Buy</td><td width="150" align="left">$50</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Feb-19-20</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">Mizuho</td><td width="250" align="left">Buy</td><td width="150" align="left">$51</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jul-26-19</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">Raymond James</td><td width="250" align="left">Outperform</td><td width="150" align="left">$36</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jul-22-19</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">SVB Leerink</td><td width="250" align="left">Outperform</td><td width="150" align="left">$34</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jul-22-19</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">Piper Jaffray</td><td width="250" align="left">Overweight</td><td width="150" align="left">$50</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jul-22-19</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">JP Morgan</td><td width="250" align="left">Overweight</td><td width="150" align="left">$38</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jul-22-19</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">Jefferies</td><td width="250" align="left">Buy</td><td width="150" align="left">$38</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jul-22-19</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">Goldman</td><td width="250" align="left">Buy</td><td width="150" align="left">$42</td></tr></table></td></tr><tr class="body-table-rating-neutral"><td class="fullview-ratings-inner"><table cellpadding="0" cellspacing="0" border="0"><tr class="body-table-rating-neutral"><td width="120" align="left">Jul-22-19</td><td width="200" align="left"><b>Initiated</b></td><td width="250" align="left">BMO Capital Markets</td><td width="250" align="left">Outperform</td><td width="150" align="left">$49</td></tr></table></td></tr></table></td></tr><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px"></td></tr><tr><td><table width="100%" cellpadding="0" cellspacing="0"><tr><td><table width="100%" cellpadding="1" cellspacing="0" border="0" id="news-table" class="fullview-news-outer"><tr><td width="130" align="right" style="white-space:nowrap">Dec-28-21 08:36AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/implied-volatility-surging-bridgebio-bbio-133601314.html" target="_blank" class="tab-link-news">Implied Volatility Surging for BridgeBio (BBIO) Stock Options</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Zacks</span> <span class="body-table-news-gain">+12.52%</span></div></div></td></tr><tr><td width="130" align="right">04:33AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/know-bridgebio-pharma-inc-nasdaq-093342663.html" target="_blank" class="tab-link-news">What You Need To Know About The BridgeBio Pharma, Inc. (NASDAQ:BBIO) Analyst Downgrade Today</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Simply Wall St.</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Dec-27-21 04:05PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.investors.com/news/technology/bbio-stock-crashes-as-pfizer-rivaling-heart-drug-flops-in-key-test/?src=A00220" target="_blank" class="tab-link-news">BridgeBio Pharma Stock Crashes As Pfizer-Rivaling Heart Drug Flops</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Investor's Business Daily</span> <span class="body-table-news-loss">-71.98%</span></div></div></td></tr><tr><td width="130" align="right">02:16PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.barrons.com/articles/bridgebio-pharma-stock-price-acoramidis-trial-51640610741?siteid=yhoof2" target="_blank" class="tab-link-news">BridgeBio Stock Plunges After Trial Fails to Meet Endpoint</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Barrons.com</span></div></div></td></tr><tr><td width="130" align="right">01:16PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.fool.com/investing/2021/12/27/why-bridgebio-pharma-stock-is-imploding-on-monday/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article" target="_blank" class="tab-link-news">Why Bridgebio Pharma Stock Is Imploding on Monday</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Motley Fool</span></div></div></td></tr><tr><td width="130" align="right">11:14AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/alnylam-pharmaceuticals-oversold-oppenheimer-analyst-161442361.html" target="_blank" class="tab-link-news">Alnylam Pharmaceuticals Oversold - Oppenheimer Analyst</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Investing.com</span></div></div></td></tr><tr><td width="130" align="right">08:12AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.barrons.com/articles/bridgebio-bbio-stock-phase-3-trial-fails-endpoint-51640610741?siteid=yhoof2" target="_blank" class="tab-link-news">BridgeBio Stock Plunges After Acoramidis Phase 3 Trial Fails to Meet Endpoint</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Barrons.com</span></div></div></td></tr><tr><td width="130" align="right">07:37AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.marketwatch.com/story/bridgebios-acoramidis-fails-to-meet-primary-endpoint-in-phase-3-attribute-cm-study-2021-12-27?siteid=yhoof2" target="_blank" class="tab-link-news">BridgeBio stock plunges after its acoramidis fails to meet primary endpoint in Phase 3 ATTRibute-CM study</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> MarketWatch</span></div></div></td></tr><tr><td width="130" align="right">07:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-month-12-120000774.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right">05:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-plunges-acoramidis-study-fails-103046545.html" target="_blank" class="tab-link-news">BridgeBio Plunges After Acoramidis Study Fails to Meet Primary Endpoint</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Investing.com</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Dec-21-21 05:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/investors-bridgebio-pharma-nasdaq-bbio-103039958.html" target="_blank" class="tab-link-news">Investors in BridgeBio Pharma (NASDAQ:BBIO) from a year ago are still down 37%, even after 9.0% gain this past week</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Simply Wall St.</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Dec-17-21 08:16PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/hedge-funds-piling-bridgebio-pharma-011650837.html" target="_blank" class="tab-link-news">Hedge Funds Are Piling Into BridgeBio Pharma, Inc. (BBIO)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span> <span class="body-table-news-gain">+15.11%</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Dec-10-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-123000226.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Dec-08-21 07:38PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/tekla-life-sciences-investors-buys-003803502.html" target="_blank" class="tab-link-news">Tekla Life Sciences Investors Buys Amgen Inc, Alkermes PLC, Novavax Inc, Sells Moderna Inc, ...</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GuruFocus.com</span></div></div></td></tr><tr><td width="130" align="right">07:38PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/tekla-healthcare-investors-buys-amgen-003802092.html" target="_blank" class="tab-link-news">Tekla Healthcare Investors Buys Amgen Inc, Guardant Health Inc, Icon PLC, Sells Abbott ...</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GuruFocus.com</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Dec-07-21 10:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.fool.com/investing/2021/12/07/8-top-pharmaceutical-stocks-to-own-in-2022/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article" target="_blank" class="tab-link-news">8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Motley Fool</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Nov-29-21 07:36AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/top-10-stock-picks-chinese-123614542.html" target="_blank" class="tab-link-news">Top 10 Stock Picks of Chinese Billionaire Lei Zhang</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Nov-24-21 08:32AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/options-traders-betting-big-move-133201773.html" target="_blank" class="tab-link-news">Are Options Traders Betting on a Big Move in BridgeBio (BBIO) Stock?</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Zacks</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Nov-19-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-helsinn-group-announce-123000176.html" target="_blank" class="tab-link-news">BridgeBio Pharma and Helsinn Group Announce Strategic Collaboration to Co-Develop and Co-Commercialize BridgeBios Novel GPX4 Inhibitor in Multiple Cancer Tumor Types</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Nov-18-21 01:21PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-secures-debt-financing-182134078.html" target="_blank" class="tab-link-news">BridgeBio Pharma Secures Debt Financing Of $750M</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Benzinga</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-secures-750-123000338.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dilutive Debt Financing</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Nov-04-21 09:25AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-bbio-reports-q3-132501591.html" target="_blank" class="tab-link-news">BridgeBio Pharma (BBIO) Reports Q3 Loss, Lags Revenue Estimates</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Zacks</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-third-quarter-113000486.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Third Quarter 2021 Financial Results and Business Update</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Nov-03-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-announces-dosing-first-113000342.html" target="_blank" class="tab-link-news">BridgeBio Pharma Announces Dosing of First Patient in Phase 1/2 Trial of Investigational Gene Therapy for Canavan Disease</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Oct-29-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-announces-collaborations-columbia-113000979.html" target="_blank" class="tab-link-news">BridgeBio Pharma Announces Collaborations with Columbia University and Mount Sinai to Develop Potential Therapies for Genetic Diseases and Cancers</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Oct-25-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-appoints-pioneering-113000968.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Appoints Pioneering National Leader in Genomics and Workforce Diversity Hannah Valantine to its Board of Directors</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Oct-18-21 05:19AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/hedge-funds-piling-bridgebio-pharma-091903420.html" target="_blank" class="tab-link-news">Hedge Funds Are Piling Into BridgeBio Pharma, Inc. (BBIO)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Oct-12-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-announces-progress-kras-113000236.html" target="_blank" class="tab-link-news">BridgeBio Pharma Announces Progress in its KRAS Portfolio, New Gene Therapy Programs, and Updates on Advancements Across its R&amp;D Pipeline Targeting Genetic Diseases and Cancers</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Oct-07-21 09:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-announces-first-publication-130000372.html" target="_blank" class="tab-link-news">BridgeBio Pharma Announces First Publication of Preclinical Data for its Potentially Best-in-Class SHP2 Inhibitor Designed for Treatment of Resistant Cancer, Showing Response in Established Non-small Cell Lung Cancer Models</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Oct-06-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-host-virtual-r-113000309.html" target="_blank" class="tab-link-news">BridgeBio Pharma to Host Virtual R&amp;D Day on October 12, 2021</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Oct-01-21 05:57PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.bizjournals.com/sanfrancisco/news/2021/10/01/bridgebio-bbio-kidney-stones-failure-encaleret.html?ana=yahoo" target="_blank" class="tab-link-news">Peninsula biotech looks to turn once-failed osteoporosis drug against rare disease</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> American City Business Journals</span></div></div></td></tr><tr><td width="130" align="right">05:00PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-announces-updated-phase-210000140.html" target="_blank" class="tab-link-news">BridgeBio Pharma Announces Updated Phase 2B Data for Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) Demonstrating Blood and Urine Calcium Normalization in Trial Participants</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Sep-15-21 08:47AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharmas-candidate-muscle-wasting-124756420.html" target="_blank" class="tab-link-news">BridgeBio Pharma's Candidate For Muscle-Wasting Disorder Wins Fast Track Tag In US</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Benzinga</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-receives-fda-fast-113000591.html" target="_blank" class="tab-link-news">BridgeBio Pharma Receives FDA Fast Track Designation for Investigational Therapy for the Treatment of Limb-girdle Muscular Dystrophy Type 2i (LGMD2i)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Sep-08-21 05:00PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-210000268.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Aug-30-21 01:36AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/tempted-sell-bridgebio-pharma-bbio-053600437.html" target="_blank" class="tab-link-news">Should You Be Tempted To Sell BridgeBio Pharma (BBIO) Stock?</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Aug-25-21 07:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-lianbio-announce-first-110000676.html" target="_blank" class="tab-link-news">BridgeBio Pharma and LianBio Announce First Patient Treated in Phase 2a Trial of Infigratinib in Patients with Gastric Cancer and Other Advanced Solid Tumors</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Business Wire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Aug-23-21 10:01AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/10-best-stocks-invest-according-140134181.html" target="_blank" class="tab-link-news">10 Best Stocks to Invest In According to Chinese Billionaire Lei Zhang</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Aug-18-21 02:22PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/baron-funds-retain-conviction-bridgebio-170853786.html" target="_blank" class="tab-link-news">Baron Funds: We Retain Conviction in BridgeBio (BBIO)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-appoints-finance-113000397.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Appoints Finance and Pharmaceutical Leaders Fred Hassan, Andrea Ellis and Douglas Dachille to its Board of Directors</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Aug-07-21 03:07AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/forecasts-heres-analysts-think-future-070729537.html" target="_blank" class="tab-link-news">New Forecasts: Here's What Analysts Think The Future Holds For BridgeBio Pharma, Inc. (NASDAQ:BBIO)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Simply Wall St.</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Aug-05-21 09:05AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-bbio-reports-q2-130501997.html" target="_blank" class="tab-link-news">BridgeBio Pharma (BBIO) Reports Q2 Loss, Tops Revenue Estimates</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Zacks</span> <span class="body-table-news-gain">+6.25%</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-reports-second-113000180.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Reports Second Quarter 2021 Financial Results and Business Update</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Aug-04-21 07:01PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-230100802.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jul-27-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-announces-clinical-collaboration-bristol-113000704.html" target="_blank" class="tab-link-news">BridgeBio Announces Clinical Collaboration with Bristol Myers Squibb to Study BBP-398, a Potentially Best-in-class SHP2 Inhibitor, in Combination with OPDIVOÂ® (nivolumab) in Advanced Solid Tumors with KRAS Mutations</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jul-13-21 10:42AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/hedge-funds-crazy-bridgebio-pharma-144212361.html" target="_blank" class="tab-link-news">Hedge Funds Are Crazy About BridgeBio Pharma, Inc. (BBIO)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jul-12-21 04:30PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-203000913.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jul-08-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-announces-collaborations-three-113000163.html" target="_blank" class="tab-link-news">BridgeBio Pharma Announces Collaborations with Three Academic Research Institutions</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> PR Newswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jul-01-21 02:15PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.investors.com/news/technology/bridgebio-pharma-stock-shows-rising-relative-strength-still-shy-of-key-threshold/?src=A00220" target="_blank" class="tab-link-news">BridgeBio Pharma Stock Sees Rising Relative Strength; Still Shy Of Key Threshold</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Investor's Business Daily</span></div></div></td></tr><tr><td width="130" align="right">12:59PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/10-best-stocks-buy-according-165927243.html" target="_blank" class="tab-link-news">10 Best Stocks to Buy According to DiDi (NYSE: DIDI)s Early Investor Billionaire Zhang Lei</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jun-28-21 07:10PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/biomea-fusion-strengthens-executive-team-231000776.html" target="_blank" class="tab-link-news">BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jun-19-21 07:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.barrons.com/articles/biotech-pro-sold-novavax-stock-bought-bridgebio-springworks-aldeyra-51623878311?siteid=yhoof2" target="_blank" class="tab-link-news">A Biotech Pro Exited Novavax Stock. Here Are Three Stocks It Bought.</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Barrons.com</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jun-14-21 04:35PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-203500600.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jun-05-21 06:31AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.fool.com/investing/2021/06/05/2-top-biotech-stocks-to-buy-for-summer-2021/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article" target="_blank" class="tab-link-news">2 Top Biotech Stocks to Buy for Summer 2021</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Motley Fool</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jun-02-21 05:44PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.investors.com/news/technology/bridgebio-stock-flashes-healthy-83-rs-rating/?src=A00220" target="_blank" class="tab-link-news">BridgeBio Stock Flashes Healthy 83 RS Rating</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Investor's Business Daily</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jun-01-21 08:02AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/fda-approves-bridgebio-pharmas-fgfr2-120209806.html" target="_blank" class="tab-link-news">FDA Approves BridgeBio Pharma's FGFR2 Inhibitor for Bile Duct Cancer</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Benzinga</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-receives-fda-fast-113000348.html" target="_blank" class="tab-link-news">BridgeBio Pharma Receives FDA Fast Track Designation for Encaleret for the Treatment of Autosomal Dominant Hypocalcemia Type 1</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right">07:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-affiliate-qed-therapeutics-110000978.html" target="_blank" class="tab-link-news">BridgeBio Pharmas Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of TRUSELTIQ (infigratinib) for Patients with Cholangiocarcinoma</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Business Wire</span></div></div></td></tr><tr><td width="130" align="right">05:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-helsinn-group-obtain-090050070.html" target="_blank" class="tab-link-news">BridgeBio Pharma and Helsinn Group Obtain FDA Approval for TRUSELTIQ</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> SmarterAnalyst</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">May-28-21 02:30PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-affiliate-qed-therapeutics-183000192.html" target="_blank" class="tab-link-news">BridgeBio Pharmas Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of TRUSELTIQ (infigratinib) for Patients with Cholangiocarcinoma</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">May-14-21 04:30PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-203000205.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span> <span class="body-table-news-gain">+5.80%</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-receives-fda-fast-113000874.html" target="_blank" class="tab-link-news">BridgeBio Pharma Receives FDA Fast Track Designation for Investigational Gene Therapy for Congenital Adrenal Hyperplasia</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">May-06-21 09:15AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-bbio-reports-q1-131501487.html" target="_blank" class="tab-link-news">BridgeBio Pharma (BBIO) Reports Q1 Loss, Lags Revenue Estimates</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Zacks</span> <span class="body-table-news-loss">-6.33%</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-reports-first-113000201.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Reports First Quarter 2021 Financial Results And Business Update</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">May-03-21 08:15AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-121500220.html" target="_blank" class="tab-link-news">SHAREHOLDER ALERT: Purcell Julie &amp; Lefkowitz LLP Is Investigating BridgeBio Pharma, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> ACCESSWIRE</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Apr-30-21 01:39PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-bbio-smart-173905599.html" target="_blank" class="tab-link-news">Is BridgeBio Pharma Inc. (BBIO) A Smart Long-Term Buy?</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Apr-24-21 12:40PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bbio-stock-buy-sell-164039911.html" target="_blank" class="tab-link-news">Is BBIO Stock A Buy or Sell?</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Apr-13-21 07:45AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-university-california-san-114500354.html" target="_blank" class="tab-link-news">BridgeBio Pharma and the University of California, San Diego Announce Collaboration to Advance Treatments for Genetically Driven Conditions</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right">07:42AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-uc-davis-114200197.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. and UC Davis Establish Collaboration to Transform Research into Potential Therapies for Genetically Driven Diseases</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right">07:40AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-roswell-park-114000371.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. and Roswell Park Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Cancers</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right">07:37AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-oregon-health-113700089.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. and Oregon Health &amp; Science University Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Diseases</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right">07:35AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-lundquist-institute-113500619.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. and The Lundquist Institute Collaborate to Advance Treatments for Genetically Driven Conditions and Cancers</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right">07:32AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-glyconet-initiate-113200190.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. and GlycoNet Initiate Collaboration to Discover Potential Treatments for Genetic Diseases through Glycomics Research</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-brown-university-announce-113000091.html" target="_blank" class="tab-link-news">BridgeBio Pharma and Brown University Announce Partnership to Drive the Advancement of Academic Innovations in Genetically Driven Diseases into Potential Therapeutics for Patients</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Apr-06-21 04:30PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-203000709.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Mar-31-21 11:46AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-locks-2b-infigratinib-global-154615286.html" target="_blank" class="tab-link-news">BridgeBio Locks $2B Infigratinib Global Partnership For Oncology Indications</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Benzinga</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-affiliate-qed-therapeutics-113000710.html" target="_blank" class="tab-link-news">BridgeBio Pharmas Affiliate QED Therapeutics and Helsinn Group Announce Strategic Collaboration to Co-Develop and Commercialize Infigratinib in Oncology</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Mar-20-21 11:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-announces-proof-concept-150000725.html" target="_blank" class="tab-link-news">BridgeBio Pharma Announces Proof-of-Concept Data of Encaleret in ADH1 at the Endocrine Societys 2021 Annual Meeting</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Mar-16-21 01:20PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/10-best-hong-kong-stocks-172040411.html" target="_blank" class="tab-link-news">10 Best Hong Kong Stocks To Buy For 2021</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Mar-02-21 04:30PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-213000986.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span> <span class="body-table-news-loss">-7.98%</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Mar-01-21 09:56AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-jumps-6-pre-market-145607393.html" target="_blank" class="tab-link-news">BridgeBio Jumps 6% Pre-Market On FDA Approval For Nulibry</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> SmarterAnalyst</span></div></div></td></tr><tr><td width="130" align="right">05:17AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-gets-first-fda-101721974.html" target="_blank" class="tab-link-news">BridgeBio Pharma Gets First FDA-Approval For Rare Genetic Metabolic Disorder</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Benzinga</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-28-21 08:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-affiliate-origin-biosciences-130000087.html" target="_blank" class="tab-link-news">BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-26-21 08:46AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/surprise-coming-bridgebio-pharma-bbio-134601814.html" target="_blank" class="tab-link-news">Is a Surprise Coming for BridgeBio Pharma (BBIO) This Earnings Season?</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Zacks</span> <span class="body-table-news-gain">+8.52%</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-25-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-reports-fourth-123000104.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results And Business Update</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-24-21 04:01PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-announce-proof-concept-210100336.html" target="_blank" class="tab-link-news">BridgeBio Pharma To Announce Proof-Of-Concept Data from ADH1 at the Endocrine Societys 2021 Annual Meeting</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-19-21 01:01PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharmas-bbp-418-muscular-180134901.html" target="_blank" class="tab-link-news">BridgeBio Pharma's BBP-418 Muscular Dystrophy Study Moves Forward With Patient Dosing</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Benzinga</span></div></div></td></tr><tr><td width="130" align="right">07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-affiliate-ml-bio-123000441.html" target="_blank" class="tab-link-news">BridgeBio Pharma and Affiliate ML Bio Solutions Announce Dosing of First Patient in Phase 2 Trial of BBP-418 in Limb Girdle Muscular Dystrophy Type 2i (LGMD2i)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-17-21 12:49PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-bbio-stock-buy-174944393.html" target="_blank" class="tab-link-news">Is BridgeBio Pharma (BBIO) Stock a Buy For 2021?</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Insider Monkey</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-12-21 08:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-announces-pricing-130000434.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Announces Pricing of Secondary Offering of Common Stock</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-11-21 04:09PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-announces-launch-210900623.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Announces Launch of Secondary Offering of Common Stock</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-05-21 04:30PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-reports-inducement-grants-213000403.html" target="_blank" class="tab-link-news">BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span> <span class="body-table-news-gain">+5.84%</span></div></div></td></tr><tr><td width="130" align="right">01:02AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-nasdaq-bbio-shareholders-060231088.html" target="_blank" class="tab-link-news">BridgeBio Pharma (NASDAQ:BBIO) Shareholders Have Enjoyed A 82% Share Price Gain</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Simply Wall St.</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Feb-02-21 07:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-affiliate-venthera-announce-123000434.html" target="_blank" class="tab-link-news">BridgeBio Pharma and Affiliate Venthera Announce Dosing of First Patient in Phase 1/2 Clinical Trial of BBP-681 for Venous, Lymphatic, and Venolymphatic Malformations</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span> <span class="body-table-news-gain">+9.72%</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jan-26-21 08:30AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-announces-completion-133000362.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span> <span class="body-table-news-loss">-5.26%</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jan-25-21 11:04PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-prices-upsized-040400092.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Prices Upsized Offering of $650 Million Convertible Senior Notes</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span> <span class="body-table-news-loss">-5.31%</span></div></div></td></tr><tr><td width="130" align="right">07:00AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-announces-proposed-120000831.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. Announces Proposed Offering of $400 Million Convertible Senior Notes</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jan-19-21 04:01PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/stockholders-bridgebio-pharma-inc-eidos-210100205.html" target="_blank" class="tab-link-news">Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jan-13-21 04:30PM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://finance.yahoo.com/news/bridgebio-pharma-inc-eidos-therapeutics-213000445.html" target="_blank" class="tab-link-news">BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for Merger</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> GlobeNewswire</span></div></div></td></tr><tr><td width="130" align="right" style="white-space:nowrap">Jan-08-21 06:56AM&nbsp;&nbsp;</td><td align="left"><div class="news-link-container"><div class="news-link-left"><a href="https://www.fool.com/investing/2021/01/08/my-best-biotech-stock-for-2021/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article" target="_blank" class="tab-link-news">My Best Biotech Stock for 2021</a></div><div class="news-link-right"><span style="color:#aa6dc0;font-size:9px"> Motley Fool</span></div></div></td></tr></table></td><td width="300" valign="top" style="padding-left: 10px"><div id="stocktwits-widget-news" class="fullview-news-outer" data-testid="quote-stocktwits-widget-news-container"></div>                                  <script type="text/javascript" defer src="//stocktwits.com/addon/widget/2/widget-loader.min.js"></script>                                  <script type="text/javascript">                                    var StocktwitsHeight = document.getElementById('news-table').clientHeight - (FinvizSettings.hasUserPremium ? 0 : 270);                                    if (StocktwitsHeight > 700 && !FinvizSettings.hasUserPremium) {                                        StocktwitsHeight -= 270;                                        var adDiv = document.createElement('div');                                        adDiv.id = 'IC_D_300x250_2';                                        adDiv.style.marginTop = '20px';                                        var stocktwitsContainer = document.getElementById('stocktwits-widget-news');                                        stocktwitsContainer.parentNode.insertBefore(adDiv, stocktwitsContainer.nextSibling);                                    }                                    function StocktwitsInit() {                                        if(typeof STWT !== 'undefined') {                                            var quoteTicker = 'BBIO';                                            STWT.Widget({                                                container: 'stocktwits-widget-news',                                                symbol: quoteTicker,                                                width: '300',                                                height: StocktwitsHeight,                                                limit: '15',                                                scrollbars: 0,                                                header: 0,                                                streaming: 'true',                                                style: { link_color: '4871a8', link_hover_color: '4871a8', header_text_color: '000000', border_color: 'transparent', border_color_2: 'transparent', divider_color: 'd3d3d3', divider_type: 'solid', box_color: 'transparent', stream_color: 'transparent', text_color: '000000', time_color: '999999', font: 'Verdana, Arial, Tahoma', font_size: 11, time_font_size: 10, username_font: 'Verdana, Arial, Tahoma', username_size: 11 }                                            });                                        }                                    }                                  </script></td></tr></table></td></tr><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px"></td></tr><tr class="table-light3-row"><td class="fullview-profile" align="left">BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include BBP-265, a small molecule stabilizer of transthyretin, or TTR, that is in an ongoing Phase 3 clinical trial for the treatment of TTR amyloidosis-cardiomyopathy, or ATTR-CM; BBP-831, a small molecule selective FGFR1-3 inhibitor which is an ongoing Phase 2 clinical trial for the treatment of achondroplasia in pediatric patients; an AAV5 gene transfer product candidate for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD; and Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, an ongoing phase 2 proof-of-concept clinical trial for Autosomal Dominant Hypocalcemia Type 1, or ADH1. The company also engages in developing products for Mendelian, genetic dermatology, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; The Regents of the University of California; Leidos Biomedical Research, Inc.; the University of California, San Diego; Johns Hopkins University and University of Florida; University of Colorado Anschutz Medical Campus; Salk Institute for Biological Studies; Maze Therapeutics; UC San Francisco; the Canadian Glycomics Network (GlycoNet); the University of California; Columbia University; Mount Sinai; and Helsinn Group, as well as a clinical collaboration with Bristol Myers Squibb to evaluate the combination of BBP-398. It also has a research collaboration and option agreement with Unnatural Products Inc. to target rare diseases with potential oncology applications. The company was founded in 2015 and is headquartered in Palo Alto, California.</td></tr><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px"></td></tr><tr><td width="100%"><div id="statements"></div></td></tr><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px"></td></tr><tr><td><table border="0" cellpadding="2" cellspacing="0" width="100%" class="body-table" bgcolor="#d3d3d3"><tr><td class="table-top-w" align="left">Insider Trading</td><td class="table-top-w" align="left">Relationship</td><td class="table-top-w" align="left">Date</td><td class="table-top-w" align="center">Transaction</td><td class="table-top-w" align="right">Cost</td><td class="table-top-w" align="right">#Shares</td><td class="table-top-w" align="right">Value ($)</td><td class="table-top-w" align="right">#Shares Total</td><td class="table-top-w" align="center">SEC Form 4</td></tr><tr class="insider-option-row" onmouseover="this.className='insider-light-row-h'" onmouseout="this.className='insider-option-row'" valign="top"><td><a href="insidertrading.ashx?oc=1214133&tc=7" class="tab-link">SCHELLER RICHARD H</td><td style="white-space:nowrap">See Remarks</td><td>Aug 04</td><td style="white-space:nowrap" align="center">Option Exercise</td><td align="right">17.00</td><td align="right">13,777</td><td align="right">234,209</td><td align="right">59,637</td><td style="white-space:nowrap" align="center"><a href="http://www.sec.gov/Archives/edgar/data/1214133/000089924321031954/xslF345X03/doc4.xml" class="tab-link">Aug 06 06:08 PM</a></td></tr><tr class="insider-sale-row-2" onmouseover="this.className='insider-light-row-h'" onmouseout="this.className='insider-sale-row-2'" valign="top"><td><a href="insidertrading.ashx?oc=1214133&tc=7" class="tab-link">SCHELLER RICHARD H</td><td style="white-space:nowrap">See Remarks</td><td>Aug 04</td><td style="white-space:nowrap" align="center">Sale</td><td align="right">53.23</td><td align="right">13,777</td><td align="right">733,317</td><td align="right">45,860</td><td style="white-space:nowrap" align="center"><a href="http://www.sec.gov/Archives/edgar/data/1214133/000089924321031954/xslF345X03/doc4.xml" class="tab-link">Aug 06 06:08 PM</a></td></tr><tr class="insider-buy-row-2" onmouseover="this.className='insider-light-row-h'" onmouseout="this.className='insider-buy-row-2'" valign="top"><td><a href="insidertrading.ashx?oc=1337801&tc=7" class="tab-link">Scott Randal W.</td><td style="white-space:nowrap">Director</td><td>Feb 17</td><td style="white-space:nowrap" align="center">Buy</td><td align="right">62.50</td><td align="right">16,000</td><td align="right">1,000,000</td><td align="right">21,000</td><td style="white-space:nowrap" align="center"><a href="http://www.sec.gov/Archives/edgar/data/1337801/000089924321007172/xslF345X03/doc4.xml" class="tab-link">Feb 18 06:21 PM</a></td></tr><tr class="insider-buy-row-2" onmouseover="this.className='insider-light-row-h'" onmouseout="this.className='insider-buy-row-2'" valign="top"><td><a href="insidertrading.ashx?oc=1780030&tc=7" class="tab-link">STEPHENSON BRIAN C</td><td style="white-space:nowrap">See Remarks</td><td>Feb 17</td><td style="white-space:nowrap" align="center">Buy</td><td align="right">62.50</td><td align="right">8,000</td><td align="right">500,000</td><td align="right">300,043</td><td style="white-space:nowrap" align="center"><a href="http://www.sec.gov/Archives/edgar/data/1743881/000089924321007227/xslF345X03/doc4.xml" class="tab-link">Feb 18 08:33 PM</a></td></tr><tr class="insider-sale-row-2" onmouseover="this.className='insider-light-row-h'" onmouseout="this.className='insider-sale-row-2'" valign="top"><td><a href="insidertrading.ashx?oc=1780408&tc=7" class="tab-link">KKR Genetic Disorder L.P.</td><td style="white-space:nowrap">10% Owner</td><td>Feb 17</td><td style="white-space:nowrap" align="center">Sale</td><td align="right">60.47</td><td align="right">3,450,000</td><td align="right">208,617,360</td><td align="right">31,060,971</td><td style="white-space:nowrap" align="center"><a href="http://www.sec.gov/Archives/edgar/data/1081714/000114036121005267/xslF345X03/form4.xml" class="tab-link">Feb 17 05:36 PM</a></td></tr></table></td></tr><table  style="margin: 21px auto 14px auto" cellpadding="0" cellspacing="0" border="0"><tr class="flex"><td class="fullview-links flex items-center" align="left" valign="center"><a target="_blank" class="tab-link" href="https://finance.yahoo.com/quote/BBIO">open in yahoo</a>&nbsp;|&nbsp<a target="_blank" class="tab-link" href="https://www.reuters.com/companies/BBIO.OQ">open in reuters</a>&nbsp;|&nbsp<a target="_blank" class="tab-link" href="https://www.marketwatch.com/investing/stock/bbio">open in marketwatch</a>&nbsp;|&nbsp<a target="_blank" class="tab-link" href="https://www.google.com/finance/quote/BBIO:NASDAQ">open in google</a></td></tr></table></div></div>            <div class="footer" style="margin-top: 20px">                <div class="footer_links">                    <a class="tab-link" href="/affiliate.ashx">affiliate</a>                    <span class="footer_dot"> â€¢ </span>                    <a class="tab-link" href="/advertise.ashx">advertise</a>                    <span class="footer_dot"> â€¢ </span>                    <a class="tab-link" href="/contact.ashx">contact</a>                    <span class="footer_dot"> â€¢ </span>                    <a class="tab-link" href="/privacy.ashx">privacy</a>                    <span class="footer_dot"> â€¢ </span>                    <a class="tab-link" href="/help/screener.ashx">help</a><br><a class="tab-link" href="/do_not_sell.ashx">Do not sell my personal information</a>                </div>                <span class="copyright">Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.</span>                <br>                Copyright Â© 2007-2021 FINVIZ.com. All Rights Reserved.</span>            </div><script type="text/javascript">SearchFocus();</script>            <script type="text/javascript" src="/js/libs/d3.js"></script>            <script type="text/javascript" src="/assets/dist/quote.a90ac297.js"></script>        <script>            function FinvizReady(fn) {              if (document.readyState != 'loading'){                fn();              } else {                document.addEventListener('DOMContentLoaded', fn);              }            }            (typeof StocktwitsInit === 'function' && FinvizReady(StocktwitsInit));            (typeof SetSearchExt === 'function' && SetSearchExt('&ty=c&ta=1&p=d'));        </script>            <script async src="https://www.googletagmanager.com/gtag/js?id=UA-3261808-1"></script>            <script>              window.dataLayer = window.dataLayer || [];              function gtag(){dataLayer.push(arguments);}              gtag('js', new Date());              gtag('set', {'dimension1': 'NotLoggedIn'});              gtag('set', {'dimension3': window.devicePixelRatio || 'unknown'});              gtag('config', 'UA-3261808-1', { sample_rate: 10, send_page_view: false });                            gtag('event', 'page_view', { page_location: location.href, page_path: location.pathname, page_title: document.title });            </script>        <script type="text/javascript">_qoptions={qacct:"p-c2W8esUZ6Q8oA"};</script><script type="text/javascript" src="https://secure.quantserve.com/quant.js"></script><noscript><img src="https://pixel.quantserve.com/pixel/p-c2W8esUZ6Q8oA.gif" style="display: none;" border="0" height="1" width="1" alt="Quantcast"/></noscript><div id="modal-elite-ad" class="modal-elite-ad">                            <div id="modal-elite-ad_content" class="modal-elite-ad_content">			                    <button id="modal-elite-ad-close" type="button" class="modal-elite-ad_close">Ã—</button>                                <!--<div id="modal-elite-ad-content-0" style="display: none">			                        <h2>Ever heard of Finviz*Elite?</h2>                                    <p>                                        Our premium service offers you real-time quotes, advanced visualizations, technical studies, and much more.<br>                                        Become Elite and make informed financial decisions.                                    </p>                                    <a href="/elite.ashx?utm_source=finviz&utm_medium=banner&utm_campaign=modal-0" id="modal-elite-ad-btn-0" class="" target="_blank">Find out more</a>                                </div>-->                                <div id="modal-elite-ad-content-1" style="display: block">			                        <h2>Upgrade your FINVIZ experience</h2>                                    <p>                                        Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features.                                        Real-time quotes, advanced&nbsp;visualizations, backtesting, and much more.                                    </p>                                    <a href="/elite.ashx?utm_source=finviz&utm_medium=banner&utm_campaign=modal-1" id="modal-elite-ad-btn-1" class="modal-elite_button" target="_blank">Learn more about FINVIZ*Elite</a>                                </div>                            </div>                         </div><script src="/js/pv.js?rev=288" async></script><script defer src="https://static.cloudflareinsights.com/beacon.min.js/v652eace1692a40cfa3763df669d7439c1639079717194" integrity="sha512-Gi7xpJR8tSkrpF7aordPZQlW2DLtzUlZcumS8dMQjwDHEnw9I7ZLyiOj/6tZStRBGtGgN6ceN6cMH8z7etPGlw==" data-cf-beacon='{"rayId":"6c4bd9053c583312","token":"e53f08f6c9e04bfd9760701085ec93b4","version":"2021.12.0","si":100}' crossorigin="anonymous"></script></body></html>